These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12608473)

  • 1. Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II.
    Rasmussen M; Fenger C; Kronborg O
    Scand J Gastroenterol; 2003 Jan; 38(1):114-8. PubMed ID: 12608473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening.
    Segnan N; Senore C; Andreoni B; Azzoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; Ederle A; Fantin A; Ferrari A; Fracchia M; Ferrero F; Gasperoni S; Recchia S; Risio M; Rubeca T; Saracco G; Zappa M;
    Gastroenterology; 2007 Jun; 132(7):2304-12. PubMed ID: 17570205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
    Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
    Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer screening with nurse-performed flexible sigmoidoscopy: results from a Canadian community-based program.
    Shapero TF; Hoover J; Paszat LF; Burgis E; Hsieh E; Rothwell DM; Rabeneck L
    Gastrointest Endosc; 2007 Apr; 65(4):640-5. PubMed ID: 17173913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds.
    Kronborg O; Jørgensen OD; Fenger C; Rasmussen M
    Scand J Gastroenterol; 2004 Sep; 39(9):846-51. PubMed ID: 15513382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance.
    Bat L; Pines A; Ron E; Niv Y; Arditi E; Shemesh E
    Am J Gastroenterol; 1986 Aug; 81(8):647-51. PubMed ID: 3740023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
    Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
    Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The yield of flexible sigmoidoscopy and double-contrast barium enema in the diagnosis of neoplasms in the large bowel in patients with a positive Hemoccult test.
    Kewenter J; Brevinge H; Engarås B; Haglind E
    Endoscopy; 1995 Feb; 27(2):159-63. PubMed ID: 7601048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Randomized population study of screening for intestinal cancer with Hemoccult-II].
    Kronborg O; Fenger C; Olsen J; Jørgensen OD; Søndergaard O
    Ugeskr Laeger; 1997 Aug; 159(33):4977-81. PubMed ID: 9281212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
    Imperiale TF; Ransohoff DF; Itzkowitz SH; Turnbull BA; Ross ME;
    N Engl J Med; 2004 Dec; 351(26):2704-14. PubMed ID: 15616205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
    Lindholm E; Brevinge H; Haglind E
    Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
    Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Female gender and other factors predictive of a limited screening flexible sigmoidoscopy examination for colorectal cancer.
    Eloubeidi MA; Wallace MB; Desmond R; Farraye FA
    Am J Gastroenterol; 2003 Jul; 98(7):1634-9. PubMed ID: 12873591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
    Graser A; Stieber P; Nagel D; Schäfer C; Horst D; Becker CR; Nikolaou K; Lottes A; Geisbüsch S; Kramer H; Wagner AC; Diepolder H; Schirra J; Roth HJ; Seidel D; Göke B; Reiser MF; Kolligs FT
    Gut; 2009 Feb; 58(2):241-8. PubMed ID: 18852257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yield of advanced adenoma and cancer based on polyp size detected at screening flexible sigmoidoscopy.
    Schoen RE; Weissfeld JL; Pinsky PF; Riley T
    Gastroenterology; 2006 Dec; 131(6):1683-9. PubMed ID: 17188959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer. A randomized study.
    Rasmussen M; Kronborg O; Fenger C; Jørgensen OD
    Scand J Gastroenterol; 1999 Jan; 34(1):73-8. PubMed ID: 10048736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.
    Hol L; van Leerdam ME; van Ballegooijen M; van Vuuren AJ; van Dekken H; Reijerink JC; van der Togt AC; Habbema JD; Kuipers EJ
    Gut; 2010 Jan; 59(1):62-8. PubMed ID: 19671542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
    Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC
    Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.